SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-068592
Filing Date
2024-08-14
Accepted
2024-08-14 08:00:29
Documents
96
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0210968-10q_elevai.htm   iXBRL 10-Q 1052735
2 CERTIFICATION ea021096801ex31-1_elevai.htm EX-31.1 12222
3 CERTIFICATION ea021096801ex31-2_elevai.htm EX-31.2 12148
4 CERTIFICATION ea021096801ex32-1_elevai.htm EX-32.1 4854
5 CERTIFICATION ea021096801ex32-2_elevai.htm EX-32.2 4846
6 GRAPHIC image_001.jpg GRAPHIC 23258
  Complete submission text file 0001213900-24-068592.txt   6469509

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE elab-20240630.xsd EX-101.SCH 72855
8 XBRL CALCULATION FILE elab-20240630_cal.xml EX-101.CAL 40825
9 XBRL DEFINITION FILE elab-20240630_def.xml EX-101.DEF 335962
10 XBRL LABEL FILE elab-20240630_lab.xml EX-101.LAB 535699
11 XBRL PRESENTATION FILE elab-20240630_pre.xml EX-101.PRE 332657
99 EXTRACTED XBRL INSTANCE DOCUMENT ea0210968-10q_elevai_htm.xml XML 757189
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 18667944940
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

IRS No.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41875 | Film No.: 241204245
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)